M&A Transactions

AEI INCOME & GROWTH FUND XXII LTD PARTNERSHIP completed a disposition involving GH Willowbrook LLC for net cash proceeds of approximately $925,000 (closed 2025-07-29).

“Partnership sold its 65% interest in the Advance Auto Parts Store to GH Willowbrook LLC, an unrelated third party. The Partnership received net cash proceeds of approximately $925,000 for the property, which resulted in a net gain of approximately $204,000. Section 9 – Financial Statements and Exhibits”

AEI INCOME & GROWTH FUND 25 LLC completed a disposition involving GH Willowbrook LLC for net cash proceeds of approximately $498,000 for the property (closed 2025-07-29).

“Partnership sold its 35% interest in the Advance Auto Parts Store to GH Willowbrook LLC, an unrelated third party. The Partnership received net cash proceeds of approximately $498,000 for the property, which resulted in a net gain of approximately $110,000. Section 9 – Financial Statements and Exhibits”

CALERES INC completed an acquisition involving Tapestry, Inc. for $120.2 million (closed 2025-08-04).

“and Purchase Agreement, dated as of February 16, 2025 (the “Purchase Agreement”), by and between the Company and Seller, as amended. The purchase price for the acquisition was $120.2 million, which included $11.5 million in cash received at the closing. Excluding cash received at the closing, the net purchase price was $108.7 million. The purchase price is subject to”

TXO Partners, L.P. completed an acquisition involving White Rock Energy, LLC for $338.6 million (closed 2025-07-31).

“The WRE Acquisition was completed under the previously reported purchase and sale agreement, dated as of May 13, 2025, and subject to customary purchase price adjustments, for cash consideration of $338.6 million, including a deferred payment of $70.0 million which is due on July 31, 2026.”

Global Asset Management Group, Inc. completed a disposition involving Steven Swank for in exchange for and in complete satisfaction of $32,000 in Notes (closed 2025-07-31).

“On July 31, 2025, the Issuer transferred 600,000 Shares of Regenecell, Inc., a Florida corporation, representing the Issuer’s entire holdings, to Steven Swank, in exchange for and in complete satisfaction of $32,000 in Notes owed to Mr. Swank by the Issuer.”

Global Asset Management Group, Inc. completed an acquisition involving Andell Holdings Corporation for 450,000 shares of its Common Stock (closed 2025-07-31).

“Agency, Inc. pursuant to a Share Exchange Agreement dated July 22, 2025. The Company acquired 100% of the issued and outstanding capital stock of Bella Rio in exchange for 450,000 shares of its Common Stock issued to Andell Holdings Corporation, the sole shareholder of Bella Rio. The transaction was conducted as a private placement under Rule 4(a)(1) of the”

BROWN & BROWN, INC. completed an acquisition involving RSC Topco, Inc. for $9.825 billion (closed 2025-08-01).

“On August 1, 2025, Brown & Brown, Inc., a Florida corporation (the “Company”), completed its previously announced acquisition of RSC Topco, Inc., a Delaware corporation (“RSC”), pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 10, 2025, by and among RSC, the Company, Encore Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), and Kelso RSC (Investor), L.P., a Delaware limited partnership, solely in its capacity as the equityholder representative (the “Kelso Investor”), pursuant to which the Company acquired RSC for an aggregate purchase price of $9.825 billion, paid at the closing of the Merger (the “Closing”), subject to certain customary post-Closing adjustments as set forth in the Merger Agreement (the “Transaction”).”

TRANSCAT INC completed an acquisition involving Essco Calibration Laboratory, LLC for $84.0 million in cash (closed 2025-08-05).

“or officer of the Company, or any associate of any such director or officer. Pursuant to the Purchase Agreement, the Company acquired all the membership units of Essco for $84.0 million in cash subject to customary holdback and adjustment provisions set forth in the Purchase Agreement. The Purchase Agreement contains various representations, warranties,”

TELEPHONE & DATA SYSTEMS INC /DE/ completed a disposition involving T-Mobile US, Inc. for approximately $4.3 billion (closed 2025-08-01).

“Buyer. The purchase price received by Array at the Closing pursuant to the Purchase Agreement, after giving effect to adjustments pursuant thereto at Closing, was approximately $4.3 billion in the aggregate (the “Adjusted Purchase Price”), with approximately $2.6 billion of the Adjusted Purchase Price being paid in cash and approximately $1.7 billion of the Adjusted”

SPECTRAL CAPITAL Corp completed an acquisition involving 42 Telecom Ltd. (closed 2025-08-01).

“On August 1, 2025, the Company completed the acquisition of 42 Telecom Ltd. in accordance with the terms of the Definitive Share Exchange Agreement.”

NIOCORP DEVELOPMENTS LTD completed an acquisition involving Elk Creek Resources Corp. ("ECRC") for aggregate purchase price of approximately $2.7 million (closed 2025-08-01).

“The Option Agreements provided for a purchase price calculated based on the appraised value per acre of the parcels of land. The aggregate purchase price was approximately $2.7 million. On the closing date of the purchase of the Property, the Company recorded a decrease in cash under current assets on its consolidated balance sheet of approximately $2.7”

SunCoke Energy, Inc. completed an acquisition involving Flame Aggregator, LLC for $325 million (closed 2025-08-01).

“and a wholly owned subsidiary of the Company (the “ Merger ”). Pursuant to the Merger Agreement, Flame Aggregator’s unitholders received cash consideration in an amount equal to $325 million, subject to certain customary adjustments for net working capital, cash and cash equivalents, indebtedness and unpaid transaction expenses, all as set forth in the Merger”

NV5 Global, Inc. underwent a change of control involving Acuren Corporation (closed 2025-08-04).

“On the Closing Date, Merger Sub I merged with and into NV5, as a result of which NV5 became a wholly owned, direct subsidiary of Acuren. Immediately thereafter, NV5 merged with and into Merger Sub II, with Merger Sub II continuing as a wholly owned, direct subsidiary of Acuren.”

Babcock & Wilcox Enterprises, Inc. completed a disposition involving Andritz AG for approximately $177 million (closed 2025-07-31).

“things, Andritz AG assumed all obligations of Andritz China under the Purchase Agreement. The total base purchase price paid pursuant to the Purchase Agreement was approximately $177 million, subject to certain offsets and adjustments. The Purchase Agreement also includes an undertaking for the Sellers and their affiliates not to compete with the Diamond business or”

E2open Parent Holdings, Inc. underwent a change of control involving WiseTech Global Limited for $3.30 per share in cash (closed 2025-08-03).

“”), E2open Parent Holdings, Inc., a Delaware corporation (the “ Company ”) and E2open Holdings, LLC, a Delaware limited liability company (“ Holdings ” and, together with the Company, the “ Company Parties ”) completed their previously announced mergers with WiseTech Global Limited, an Australian public company limited by shares (“ Parent ”), Emerald Parent Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“ Company Merger Sub ”), and Emerald Holdings Merger Sub LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (“ Holdings Merger Sub ” and, together with Parent and Company Merger Sub, the “ Parent Parties ”).”

Silvaco Group, Inc. completed an acquisition involving Mixel Group, Inc. (closed 2025-08-01).

“On August 1, 2025, Silvaco Group, Inc., a Delaware corporation (the “Company”), Mixel Group, Inc., a California corporation (“Mixel”), the Ashraf K. Takla Living Trust and the Nadia T. Takla Irrevocable Gift Trust (collectively, the “Sellers”) consummated the acquisition by the Company of all outstanding shares of common stock of Mixel (the “Acquisition”) pursuant to a Stock Purchase Agreement (the “Stock Purchase Agreement”) by and among the Company, Mixel and the Sellers.”

TIC Solutions, Inc. completed an acquisition involving NV5 Global, Inc. for 1.1523 shares of Acuren Common Stock and cash in the amount of $10.00 (closed 2025-08-04).

“the First Merger (the “First Effective Time”), other than Excluded Shares (as defined below) and Appraisal Shares (as defined below) was converted into the right to receive (i) 1.1523 shares of Acuren Common Stock (the “Per-Share Share Consideration”) and (ii) cash in the amount of $10.00 (the “Per-Share Cash Consideration” and, together with the Per-Share”

BAR HARBOR BANKSHARES completed an acquisition involving Guaranty Bancorp, Inc. for approximately $39.2 million in shares of Bar Harbor Common Stock (closed 2025-07-31).

“outstanding immediately prior to the Effective Time remained outstanding and was unchanged by the Merger. The total consideration payable by Bar Harbor consists of approximately $39.2 million in shares of Bar Harbor Common Stock based on the closing price of Bar Harbor Common Stock as reported on the NYSE American of $29.04 as of July 31, 2025. ​ The foregoing”

Andersons, Inc. completed an acquisition involving MPC Investment LLC ("Marathon") for $425.0 million, inclusive of $40.0 million of working capital (closed 2025-07-31).

“On July 31, 2025, The Andersons, Inc. (the "Company") entered into a unit purchase agreement (the "Purchase Agreement") with MPC Investment LLC ("Marathon") to acquire the remaining 49.9% ownership interest in The Andersons Marathon Holdings LLC ("TAMH") for $425.0 million, inclusive of $40.0 million of working capital. The transaction closed on July 31, 2025, funded with cash on hand and debt from existing credit facilities.”

ARRAY DIGITAL INFRASTRUCTURE, INC. completed a disposition involving T-Mobile US, Inc. for approximately $4.3 billion in the aggregate (closed 2025-08-01).

“Buyer. The purchase price received by Array at the Closing pursuant to the Purchase Agreement, after giving effect to adjustments pursuant thereto at Closing, was approximately $4.3 billion in the aggregate (the “Adjusted Purchase Price”), with approximately $2.6 billion of the Adjusted Purchase Price being paid in cash and approximately $1.7 billion of the Adjusted”

SITE Centers Corp. completed a disposition involving RA2 – Winter Garden Village LLC for $165 million in cash (closed 2025-08-01).

“On August 1, 2025, a subsidiary of SITE Centers Corp. completed the previously announced sale of its interests in Winter Garden Village (Orlando, Florida) to RA2 – Winter Garden Village LLC for a price of $165 million in cash, subject to adjustment for certain closing pro-rations, allocations and credits.”

BMP AI Technologies, Inc. completed an acquisition involving Ahmed Mohammed Zaheer Uddin (closed 2025-07-29).

“On July 29, 2025, NeuralBase AI Ltd. (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with Ahmed Mohammed Zaheer Uddin (the “Seller”), pursuant to which the Company acquired certain proprietary artificial intelligence assets known as HeartEase – AI-Powered Early Detection of Heart Abnormalities (the “Acquired Assets”).”

Keenova Therapeutics plc completed an acquisition involving Endo, Inc. for approximately $1.31 in cash and 0.2575 of a Mallinckrodt ordinary share (closed 2025-07-31).

“On July 31, 2025, pursuant to the terms of the Transaction Agreement, at the effective time of the Merger (the “ Merger Effective Time ”), each share of common stock, par value $0.001 per share, of Endo (the “ Endo common stock ”) issued and outstanding as of immediately prior to the Merger Effective Time, other than the shares of Endo common stock owned by Endo, any Endo subsidiary, Mallinckrodt, Merger Sub or any of their respective subsidiaries, was cancelled and converted into the right to receive approximately $1.31 in cash (the “ Per Share Cash Consideration ”) and 0.2575 of a Mallinckrodt ordinary share (the “ Per Share Stock Consideration, ”), without interest and subject to applicable withholding.”

Endo LP completed an acquisition involving Mallinckrodt plc for 0.2575 of an ordinary share of Mallinckrodt and approximately $1.31 in cash per share (closed 2025-07-31).

“Stock owned by the Company, any Company subsidiary, Mallinckrodt, Merger Sub or any of their respective subsidiaries, was cancelled and converted into the right to receive (i) 0.2575 of an ordinary share of Mallinckrodt (the “ Mallinckrodt Ordinary Shares ”) (such number of Mallinckrodt Ordinary Shares, the “ Per Share Stock Consideration ”) and approximately”

STEELE BANCORP INC completed an acquisition involving Northumberland Bancorp for 1.185 shares of Steele common stock (closed 2025-08-01).

“its name to Central Penn Bank & Trust (“Central Penn”). Pursuant to the Merger Agreement, for each share of Northumberland common stock, Northumberland shareholders will receive 1.185 shares of Steele common stock and will receive cash in lieu of fractional shares. The total consideration payable to Northumberland shareholders is comprised of an aggregate of”

EOG RESOURCES INC completed an acquisition involving Encino Acquisition Partners, LLC for $5.6 billion in cash (closed 2025-08-01).

“Company from the Sellers, partially through the acquisition of Blocker Corp and partially through the direct purchase of equity interests in the Company, for a purchase price of $5.6 billion in cash, inclusive of repayment of debt and subject to customary working capital and other adjustments. The description of the Purchase Agreement and the transactions”

SUPERNUS PHARMACEUTICALS, INC. completed an acquisition involving Sage Therapeutics, Inc. for approximately $561 million (closed 2025-07-31).

“which is calculated and payable in accordance with the CVR Agreement. The aggregate consideration to be paid by Purchaser to complete the Offer and the Merger is approximately $561 million (exclusive of amounts that may be payable pursuant to the CVRs), without giving effect to related transaction fees and expenses. The foregoing description of the Merger”

Sage Therapeutics, Inc. underwent a change of control involving Supernus Pharmaceuticals, Inc. for $8.50 per Share in cash, plus one contingent value right per Share representing the right to receive up to $3.50 per Share (closed 2025-07-31).

“a tender offer (the “Offer”) on July 2, 2025, to acquire all of the outstanding shares of common stock of the Company, par value $0.0001 per share (the “Shares”) for (i) $8.50 per Share, net to the seller in cash, without interest and subject to any withholding of Taxes, (the “Closing Amount”), plus (ii) one contingent value right per Share (a “CVR”),”

Adaptimmune Therapeutics PLC completed a disposition involving USWM CT, LLC, a subsidiary of US WorldMeds Partners, LLC for $55 million in cash upon consummation of the Transaction, and Purchaser has agreed to make future payments of up to $30 million (closed 2025-07-31).

“rights, regulatory authorizations, contracts, equipment, inventory, and other related assets (together with the Products, the “Transferred Assets”). Purchaser paid Adaptimmune $55 million in cash upon consummation of the Transaction, and Purchaser has agreed to make future payments of up to $30 million to Adaptimmune upon the achievement of certain regulatory and”

BOYD GAMING CORP completed a disposition involving TSE Holdings Ltd. for aggregate cash consideration of $1.758 billion (closed 2025-07-31).

“entirely by Boyd Entities, but utilizing certain sports betting data feeds provided by FanDuel or its affiliate. Boyd Interactive was paid aggregate cash consideration of $1.758 billion in connection with the transactions contemplated by the Purchase Agreement. For additional information regarding the Purchase Agreement, see the Current Report on Form 8-K”

StoneX Group Inc. completed an acquisition involving RTS Investor Corp. for aggregate consideration of (i) $610,566,926 in cash, subject to post-closing adjustment as provided in the Merger Agreement and (ii) 3,085,554 shares of common (closed 2025-07-31).

“the Merger Agreement, in connection with the Merger, StoneX paid the equityholders, option holders and holders of stock appreciation rights of RTS aggregate consideration of (i) $610,566,926 in cash, subject to post-closing adjustment as provided in the Merger Agreement and (ii) 3,085,554 shares (the “Stock Consideration”) of common stock, par value $0.01 per share,”

CBL & ASSOCIATES PROPERTIES INC completed an acquisition involving Washington Prime Group for $178.9 million (closed 2025-07-29).

“CBL & Associates Properties, Inc. (the "Company") acquired four enclosed regional malls for $178.9 million from Washington Prime Group on July 29, 2025.”

ASBURY AUTOMOTIVE GROUP INC completed an acquisition involving The Herb Chambers Companies (closed 2025-07-21).

“On July 21, 2025, Asbury Automotive Group, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Report”) with the Securities and Exchange Commission (the “SEC”) to report the completion of the acquisition by Asbury Automotive Group, LLC (“Purchaser”), a Delaware limited liability company and a wholly-owned subsidiary of the Company, of substantially all of the assets, including real property and businesses of The Herb Chambers Companies, pursuant to a Purchase and Sale Agreement with various entities that comprise the Herb Chambers automotive dealerships group.”

ImageneBio, Inc. underwent a change of control involving Inmagene Biopharmaceuticals for Each Inmagene Share was converted into the right to receive 0.0030510 shares of Ikena Common Stock (closed 2025-07-25).

“Time were canceled and ceased to exist, and no consideration was delivered in exchange therefor, (b) each then-outstanding Inmagene Share was converted into the right to receive 0.0030510 shares of Ikena Common Stock, par value $0.001 per share (“ Ikena Common Stock ”) (such ratio, the “ Exchange Ratio ”) and (c) each then-outstanding option to purchase Inmagene”

Northwest Bancshares, Inc. completed an acquisition involving Penns Woods Bancorp, Inc. (closed 2025-07-25).

“completed its previously announced merger with Penns Woods Bancorp, Inc., a Pennsylvania corporation”

NexPoint Real Estate Finance, Inc. completed a disposition involving NexBank Capital, Inc. for $60.0 million (closed 2025-07-22).

“On July 22, 2025, NexPoint Real Estate Finance, Inc. (the “Company”) completed the sale of the Hudson Montford multifamily property, located in Charlotte, North Carolina (also known as Montford at Madison Park), comprising of approximately 204 units, for $60.0 million (the “Montford Transaction”) pursuant to a Membership Interest Purchase Agreement, dated June 4, 2025 (the “Agreement”), by and among NREF OP IV, L.P. and NexPoint Montford Investment Co, LLC, subsidiaries of the Company, and NexBank Capital, Inc.”

Deep Isolation Nuclear, Inc. completed an acquisition involving Deep Isolation Inc. (closed 2025-07-23).

“On July 23, 2025 we completed the Merger, as a result of which Acquisition Sub was merged with and into Deep Isolation, with Deep Isolation continuing as the surviving corporation of the Merger and becoming our wholly owned subsidiary.”

PENNS WOODS BANCORP INC underwent a change of control involving Northwest Bancshares, Inc. for 20.6 million shares of Northwest Common Stock (closed 2025-07-25).

“Merger Agreement, a copy of which is filed hereto as Exhibit 2.1 and incorporated herein by reference. The total aggregate consideration payable in the Merger was approximately 20.6 million shares of Northwest Common Stock. The information set forth in the Introduction is incorporated herein by reference into this Item 2.01.”

SIGMATRON INTERNATIONAL INC underwent a change of control involving Transom Axis AcquireCo, LLC (Parent) and Transom Axis MergerSub, Inc. (Purchaser) for $3.02 per share in cash (closed 2025-07-28).

“capture new industry opportunities.” Transaction Details Transom’s tender offer to acquire all issued and outstanding shares of SigmaTron’s common stock, at a purchase price of $3.02 per share in cash, expired as scheduled at one minute after 11:59 p.m., Eastern Time, on July 24, 2025, and was not extended. Equiniti Trust Company, LLC, the depositary and”

Signature Holdings Corp underwent a change of control involving Intaurelius LLC for $25,000 in cash on hand of Acquiror and $25,000 in a promissory note to the Seller (closed 2025-07-21).

“On July 21, 2025, a change in control of Signature Holdings Corporation (the “Company”) occurred pursuant to the consummation of a stock purchase agreement, entered into on July 21, 2025 between Intaurelius LLC (the “Acquiror”) and Greg Aurre III (the “Seller”.) As a result of the transaction, Acquiror acquired control of 83.1% of the outstanding shares of the Company’s common stock and now has effective control over the Company. The consideration paid in connection with the transaction consisted of $25,000 in cash on hand of Acquiror and $25,000 in a promissory note to the Seller”

Verve Therapeutics, Inc. underwent a change of control involving Eli Lilly and Company for $10.50 per share in cash plus one contingent value right (CVR) per share with potential additional payment of up to $3.00 per CVR (closed 2025-07-25).

“to purchase all of the issued and outstanding shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Company Common Stock”) in exchange for (i) $10.50 per Share, net to the stockholder in cash, without interest (the “Cash Consideration”) and less any applicable tax withholding, plus (ii) one non-tradable contingent value right”

SIMMONS FIRST NATIONAL CORP completed a disposition involving Morgan Stanley & Co., LLC for approximately $2.4 billion (closed 2025-07-23).

“On July 23, 2025, Simmons First National Corporation (the “ Company ”) and its subsidiaries completed steps taken to reposition its consolidated balance sheet (the “ Transaction ”). In the Transaction, the Company and its subsidiaries, as applicable, reclassified its held-to-maturity investment securities to available for sale. The Company and its subsidiaries, as applicable, then sold approximately $3.2 billion (amortized cost basis) of its investment securities to Morgan Stanley & Co., LLC based on fair market value for an aggregate price of approximately $2.4 billion.”

TRIUMPH GROUP INC underwent a change of control involving Warburg Pincus LLC and Berkshire Partners LLC for $26.00 per share in cash (closed 2025-07-24).

“as of the Effective Time, has not failed to perfect, or not effectively waived, withdrawn or lost rights to appraisal under the DGCL) was converted into the right to receive $26.00 in cash, without interest and subject to applicable tax withholdings (the “ Merger Consideration ”) and, as of the Effective Time, all such shares of Common Stock are no longer”

Lightstone Value Plus REIT I, Inc. completed a disposition involving 355 Exterior Development Holdings LLC and 399 Exterior Development Holdings LLC (collectively, the Exterior Street Project Buyers) for $84.0 million (closed 2025-07-18).

“of a mixed-use multifamily residential and commercial retail project (the “Exterior Street Project”) to the Exterior Street Project Buyers for a contractual sales price of $84.0 million . Subsequently during the second quarter of 2025, the Exterior Street Buyers made nonrefundable payments totaling $1.3 million to the Company in order to extend the outside”

ESSA Bancorp, Inc. underwent a change of control involving CNB Financial Corporation for 0.8547 of a share of common stock, no par value per share, of CNB (closed 2025-07-23).

“Time”), each share of common stock, $0.01 par value, of ESSA (“ESSA Common Stock”) outstanding immediately prior to the Effective Time was converted into the right to receive 0.8547 of a share of common stock, no par value per share, of CNB (“CNB Common Stock” and such consideration, the “Merger Consideration”). Holders of ESSA Common Stock will receive cash”

HEALTHY EXTRACTS INC. underwent a change of control involving Donald Swanson for 13,075,920 shares of our common stock which represents 77.5% of our issued and outstanding common stock after the transaction (closed 2025-07-19).

“membership interests of GUSA, which is now our wholly-owned subsidiary. As consideration for the purchase, we issued thirteen million seventy-five thousand nine hundred twenty (13,075,920) shares of our common stock (the “Purchase Shares”) which represents 77.5% of our issued and outstanding common stock after the transaction, to Swanson. In addition, Swanson was”

CNB FINANCIAL CORP/PA completed an acquisition involving ESSA Bancorp, Inc. for 0.8547 shares of CNB common stock (closed 2025-07-23).

“Subject to the terms and conditions of the Merger Agreement, at the effective time of the Merger, each share of ESSA common stock was converted into the right to receive 0.8547 shares of CNB common stock, with cash payable in lieu of any fractional shares. A copy of CNB’s press release dated July 24, 2025, announcing the completion of the Merger, is”

Alset Inc. completed an acquisition involving Chan Heng Fai for $83,000,000 in the form of a promissory note convertible into newly issued shares of the Company's common stock (closed 2025-07-23).

“Chief Executive Officer and largest stockholder, pursuant to which the Company purchased from Mr. Chan all of the outstanding shares of NEAPI for a purchase price of $83,000,000 in the form of a promissory note convertible into newly issued shares of the Company’s common stock (the “Convertible Note”). The Convertible Note bears a simple interest rate of”

Elevation Oncology, Inc. completed an acquisition involving Concentra Merger Sub VI, Inc. (a wholly owned subsidiary of Concentra Biosciences, LLC) for $0.36 per share plus one contingent value right (CVR) per share (closed 2025-07-23).

“Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, on July 23, 2025, Merger Sub completed a tender offer to purchase all of the Company’s outstanding shares of common stock, par value $0.0001 per share (the “ Common Stock ” and shares of Common Stock, “ Shares ”), in exchange for (i) $0.36 in cash per Share (the “Cash Amount”); plus (ii) one non-transferable contractual contingent value right per Share (each, a “CVR,” and each CVR together with the Cash Amount, the “ Offer Price ”), which CVR represents the right to receive potential payments pursuant to the terms and subject to the conditions of the contingent value rights agreement (the “ CVR Agreement ”), dated July 23, 2025, by and among Concentra, Merger Sub, Broadridge Corporate Issuer Solutions, LLC, a Pennsylvania limited liability company, and Fortis Advisors LLC, a Delaware limited liability company, all subject to and in accordance with the terms and conditions set forth in the Offer”

Lantheus Holdings, Inc. completed an acquisition involving Life Medical Group Limited for $350 million (closed 2025-07-21).

“the Transaction pursuant to the Agreement. In accordance with the Agreement, upon the closing of the Transaction, the Purchaser paid the Seller an upfront cash payment of $350 million (following applicable purchase price adjustments under the Agreement) in exchange for all of the outstanding share capital of Life Molecular. The foregoing description of the”